Drugs / Black Cohosh

Trials 11

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT00068185 Aug 2003 → Jul 2008 — National Center for Complementary and Integrative Health (NCCIH) Terminated No outcome recorded Stop: Business
Phase 1 NCT00010959 Feb 2001 → Feb 2002 — National Center for Complementary and Integrative Health (NCCIH) Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT00064831 Jul 2003 → Feb 2007 — National Center for Complementary and Integrative Health (NCCIH) Completed No outcome recorded
Phase 23 trials · 1 missed
Phase 2 NCT02952742 Nov 2016 → Nov 2018 — Midwestern Regional Medical Center Withdrawn No outcome recorded Stop: Business
Phase 2 NCT00066144 Apr 2003 → Apr 2006 — National Center for Complementary and Integrative Health (NCCIH) Completed Missed primary
Phase 2 NCT00010712 Sep 1999 → Jul 2005 postmenopausal osteoporosis National Center for Complementary and Integrative Health (NCCIH) Completed No outcome recorded
Phase 33 trials
Phase 3 NCT01487694 Dec 2011 → Oct 2012 — Mahidol University Unknown No outcome recorded
Phase 3 NCT00299364 Sep 2004 → May 2005 — Schaper & Bruemmer GmbH & Co KG Completed No outcome recorded
Phase 3 NCT02184364 Nov 1998 → Sep 2000 — Boehringer Ingelheim Completed No outcome recorded
Phase 41 trial · 1 missed
Phase 4 NCT00169299 Jun 2001 → Sep 2004 — Kaiser Permanente Unknown Missed primary
Phase not applicable1 trial
— NCT00061711 Jul 2000 → Dec 2005 — National Institute on Aging (NIA) Completed No outcome recorded
Comparator or background therapy3 trials
Phase 3 NCT02093650 Comparator Mar 2014 → Mar 2016 — Navamindradhiraj University Unknown No outcome recorded
Phase 3 NCT01481025 Comparator Nov 2011 → Jun 2012 — Phytopharm Consulting Brazil Unknown No outcome recorded
Phase 4 NCT02467686 Comparator Jan 2014 → Sep 2017 — Irmandade da Santa Casa de Misericordia de Sao Paulo Unknown No outcome recorded

News releases announcing trial results or a regulatory action · 1

DateIssuerRelease
2018-08-01 Schaper & Bruemmer GmbH & Co KG Regulatory Remifemin plus Johanniskraut: Bewährte Wirkstoffkombination mit neuer Zulassung schaper-bruemmer.de ↗

All press releases naming this drug 1 release

DateIssuerRelease

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 14 sources stand behind the page.

FieldValueCited text
Known as black cohosh “Cimicifuga racemosa (black cohosh) rhizome and root extract have been used to treat menopausal symptoms.” NCT01487694 ↗
7

“Trifolium pratense (red clover) and Cimicifuga racemosa (black cohosh)” NCT00010959 ↗

“Cimicifuga racemosa (Black Cohosh)” NCT00061711 ↗

NCT00010712 ↗

NCT02952742 ↗

NCT00068185 ↗

NCT00299364 ↗

NCT00169299 ↗

Known as BCE “Black Cohosh Extract (BCE)” NCT00064831 ↗
Known as black cohosh extract ClinicalTrials.gov intervention name — accepted as the source's own label NCT02093650 ↗
1

NCT00064831 ↗

Known as Cimicifuga ClinicalTrials.gov intervention name — accepted as the source's own label NCT01481025 ↗
Known as Cimicifuga Herbarium ClinicalTrials.gov intervention name — accepted as the source's own label NCT01481025 ↗
Known as Cimicifuga racemosa “For centuries, black cohosh (Cimicifuga racemosa) has been used worldwide for women's health.” NCT00010712 ↗
5

NCT02467686 ↗

NCT00010959 ↗

NCT00061711 ↗

NCT00066144 ↗

NCT01487694 ↗

Known as iCR “Black Cohosh (iCR) or tibolone” NCT00299364 ↗
Known as Klimadynon ClinicalTrials.gov intervention name — accepted as the source's own label NCT02184364 ↗
Modality Traditional medicine (herbal / TCM) “For centuries, black cohosh (Cimicifuga racemosa) has been used worldwide for women's health.” NCT00010712 ↗
Route Oral “orally” NCT00299364 ↗